Targeting Muscarinic Acetylcholine Receptors In Schizophrenia: The Latest Research

Posted on:March 14, 2023
Last Updated: March 21, 2023
Time to read: 9 minutes

For decades, researchers have been investigating the role of muscarinic acetylcholine receptors (mAChRs) in the development and progression of schizophrenia.

In recent years, there has been a surge of interest in the potential of mAChRs as a therapeutic target for schizophrenia.

This article will provide an overview of current research on mAChRs and their potential implications for diagnosing and treating schizophrenia.

We will explore the mechanisms by which mAChRs may contribute to the pathophysiology of schizophrenia, the evidence supporting their involvement in the disorder and the latest findings on novel ligands in clinical development that target mAChRs.

By the end of this article, you will have a greater understanding of the potential of mAChRs as a target for the treatment of schizophrenia and the exciting new developments that are on the horizon.

References